VBI Vaccines
VBIV
#10529
Rank
A$2.82 M
Marketcap
A$0.09840
Share price
0.00%
Change (1 day)
-89.73%
Change (1 year)

VBI Vaccines (VBIV) - Total liabilities

Total liabilities on the balance sheet as of March 2024 : A$0.12 Billion

According to VBI Vaccines 's latest financial reports the company's total liabilities are A$0.12 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

VBI Vaccines - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31A$0.13 B45.9%
2021-12-31A$91.58 M86.95%
2020-12-31A$48.98 M1.03%
2019-12-31A$48.48 M-13.47%
2018-12-31A$56.03 M69.09%
2017-12-31A$33.13 M13.61%
2016-12-31A$29.16 M337.98%
2015-12-31A$6.65 M
2015-03-31A$0.36 M35.3%
2014-03-31A$0.26 M16.44%
2013-03-31A$0.23 M-66.3%
2012-03-31A$0.68 M-98.57%
2011-03-31A$47.92 M21450.06%
2010-03-31A$0.22 M-3.34%
2009-03-31A$0.23 M9.37%
2008-03-31A$0.21 M19.97%
2007-03-31A$0.17 M-49.54%
2006-03-31A$0.34 M9.18%
2005-03-31A$0.31 M34.96%
2004-03-31A$0.23 M-26.95%
2003-03-31A$0.32 M29.33%
2002-03-31A$0.24 M161.81%
2001-03-31A$0.09 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Onconova Therapeutics
ONTX
A$18.31 M-84.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
A$0.53 B 339.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
A$63.79 M-47.68%๐Ÿ‡บ๐Ÿ‡ธ USA